• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TraFo-CRISPR:通过瞬时泡沫病毒载体介导的CRISPR/Cas9组件递送实现增强的基因组工程

TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components.

作者信息

Lindel Fabian, Dodt Carolin R, Weidner Niklas, Noll Monique, Bergemann Fabian, Behrendt Rayk, Fischer Sarah, Dietrich Josephine, Cartellieri Marc, Hamann Martin V, Lindemann Dirk

机构信息

Institute of Virology, Medical Faculty "Carl Gustav Carus," Technische Universität Dresden, 01307 Dresden, Germany; CRTD/DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, 01307 Dresden, Germany.

Institute of Immunology, Technische Universität Dresden, 01307 Dresden, Germany.

出版信息

Mol Ther Nucleic Acids. 2019 Dec 6;18:708-726. doi: 10.1016/j.omtn.2019.10.006. Epub 2019 Oct 17.

DOI:10.1016/j.omtn.2019.10.006
PMID:31726388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6859288/
Abstract

The adaptation of CRISPR/Cas technology for use in mammals has revolutionized genome engineering. In particular with regard to clinical application, efficient expression of Cas9 within a narrow time frame is highly desirable to minimize the accumulation of off-target editing. We developed an effective, aptamer-independent retroviral delivery system for Cas9 mRNAs that takes advantage of a unique foamy virus (FV) capability: the efficient encapsidation and transfer of non-viral RNAs. This enabled us to create a FV vector toolbox for efficient, transient delivery (TraFo) of CRISPR/Cas9 components into different target tissues. Co-delivery of Cas9 mRNA by TraFo-Cas9 vectors in combination with retroviral, integration-deficient single guide RNA (sgRNA) expression enhanced efficacy and specificity of gene-inactivation compared with CRISPR/Cas9 lentiviral vector systems. Furthermore, separate TraFo-Cas9 delivery allowed the optional inclusion of a repair matrix for efficient gene correction or tagging as well as the addition of fluorescent negative selection markers for easy identification of off-target editing or incorrect repair events. Thus, the TraFo CRISPR toolbox represents an interesting alternative technology for gene inactivation and gene editing.

摘要

将CRISPR/Cas技术应用于哺乳动物已彻底改变了基因组工程。特别是在临床应用方面,非常希望在狭窄的时间范围内高效表达Cas9,以尽量减少脱靶编辑的积累。我们开发了一种有效的、不依赖适体的逆转录病毒递送系统,用于递送Cas9 mRNA,该系统利用了泡沫病毒(FV)的一种独特能力:高效包装和转移非病毒RNA。这使我们能够创建一个FV载体工具箱,用于将CRISPR/Cas9组件高效、瞬时递送至不同靶组织(TraFo)。与CRISPR/Cas9慢病毒载体系统相比,通过TraFo-Cas9载体共递送Cas9 mRNA并结合逆转录病毒、整合缺陷型单向导RNA(sgRNA)表达,增强了基因失活的效力和特异性。此外,单独的TraFo-Cas9递送允许选择性地加入修复基质以进行有效的基因校正或标记,以及加入荧光阴性选择标记以易于识别脱靶编辑或错误修复事件。因此,TraFo CRISPR工具箱代表了一种用于基因失活和基因编辑的有趣替代技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/2853438421ed/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/210fb0461fe0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/f566443b0220/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/e6d4c9f0bda7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/598792e5be04/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/268c288ec8cd/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/66e114ae3e59/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/2853438421ed/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/210fb0461fe0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/f566443b0220/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/e6d4c9f0bda7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/598792e5be04/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/268c288ec8cd/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/66e114ae3e59/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7661/6859288/2853438421ed/gr7.jpg

相似文献

1
TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components.TraFo-CRISPR:通过瞬时泡沫病毒载体介导的CRISPR/Cas9组件递送实现增强的基因组工程
Mol Ther Nucleic Acids. 2019 Dec 6;18:708-726. doi: 10.1016/j.omtn.2019.10.006. Epub 2019 Oct 17.
2
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
3
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing.整合酶缺陷型慢病毒载体作为用于高效CRISPR/Cas9介导的基因编辑的一体化平台
Mol Ther Methods Clin Dev. 2017 Apr 19;5:153-164. doi: 10.1016/j.omtm.2017.04.002. eCollection 2017 Jun 16.
4
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.支架介导的非病毒递送平台用于基于 CRISPR/Cas9 的基因组编辑。
Acta Biomater. 2019 May;90:60-70. doi: 10.1016/j.actbio.2019.04.020. Epub 2019 Apr 9.
5
Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.构建一种单载体多重 CRISPR/Cas9 编辑系统以抑制家蚕中的核型多角体病毒复制。
Virol Sin. 2019 Aug;34(4):444-453. doi: 10.1007/s12250-019-00121-4. Epub 2019 Jun 19.
6
CRISPR/Cas9; A robust technology for producing genetically engineered plants.CRISPR/Cas9:一种用于培育基因工程植物的强大技术。
Cell Mol Biol (Noisy-le-grand). 2018 Nov 30;64(14):31-38.
7
Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.利用CRISPR-Cas9系统对枯草芽孢杆菌基因组进行编辑
Appl Environ Microbiol. 2016 Aug 15;82(17):5421-7. doi: 10.1128/AEM.01453-16. Print 2016 Sep 1.
8
Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.开发用于谷氨酸棒杆菌的 CRISPR/Cas9 基因组编辑工具包。
Microb Cell Fact. 2017 Nov 16;16(1):205. doi: 10.1186/s12934-017-0815-5.
9
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.利什曼原虫中CRISPR-Cas9介导的基因组编辑
mBio. 2015 Jul 21;6(4):e00861. doi: 10.1128/mBio.00861-15.
10
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.CRISPR-Cas9 基因编辑系统的治疗应用传递策略。
J Control Release. 2017 Nov 28;266:17-26. doi: 10.1016/j.jconrel.2017.09.012. Epub 2017 Sep 11.

引用本文的文献

1
Thirteenth International Foamy Virus Conference-Meeting Report.第十三届国际泡沫病毒会议——会议报告
Viruses. 2025 Jul 31;17(8):1071. doi: 10.3390/v17081071.
2
Viral and nonviral nanocarriers for CRISPR-based gene editing.用于基于CRISPR的基因编辑的病毒和非病毒纳米载体。
Nano Res. 2024 Oct;17(10):8904-8925. doi: 10.1007/s12274-024-6748-5. Epub 2024 Jun 20.
3
Tailored Viral-like Particles as Drivers of Medical Breakthroughs.定制病毒样颗粒作为医学突破的驱动力。

本文引用的文献

1
Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.通过基于慢病毒衣壳的仿生纳米颗粒递呈 Cas9/sgRNA 核糖核蛋白(RNP),实现高效的“打了就跑”基因组编辑。
Nucleic Acids Res. 2019 Sep 26;47(17):e99. doi: 10.1093/nar/gkz605.
2
Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.通过慢病毒样仿生纳米颗粒传递 SaCas9 mRNA 用于瞬时表达和高效基因组编辑。
Nucleic Acids Res. 2019 May 7;47(8):e44. doi: 10.1093/nar/gkz093.
3
CARs of the future.
Int J Mol Sci. 2024 Jun 18;25(12):6699. doi: 10.3390/ijms25126699.
4
Breaking genetic shackles: The advance of base editing in genetic disorder treatment.打破基因枷锁:碱基编辑在遗传疾病治疗中的进展。
Front Pharmacol. 2024 Mar 6;15:1364135. doi: 10.3389/fphar.2024.1364135. eCollection 2024.
5
Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells.通过蛋白聚糖缺陷型包装细胞高效生产不含抑制剂的含泡沫病毒糖蛋白的逆转录病毒载体。
Mol Ther Methods Clin Dev. 2022 Aug 1;26:394-412. doi: 10.1016/j.omtm.2022.07.004. eCollection 2022 Sep 8.
6
New Advances in Using Virus-like Particles and Related Technologies for Eukaryotic Genome Editing Delivery.病毒样颗粒及其相关技术在真核基因组编辑传递中的新进展。
Int J Mol Sci. 2022 Aug 6;23(15):8750. doi: 10.3390/ijms23158750.
7
CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles.利用非整合噬菌体嵌合逆转录病毒样颗粒在人诱导多能干细胞中进行 CRISPR/Cas9 介导的基因敲除和等位基因间基因转换。
BMC Biol. 2022 Jan 7;20(1):8. doi: 10.1186/s12915-021-01214-x.
8
Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing.病毒样颗粒介导的CRISPR/Cas9递送用于高效安全的基因组编辑
Life (Basel). 2020 Dec 21;10(12):366. doi: 10.3390/life10120366.
9
Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools.使用“适配性良好”的基因组编辑工具对非酒精性脂肪性肝病(NAFLD)进行建模
Cells. 2020 Dec 1;9(12):2572. doi: 10.3390/cells9122572.
10
Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control.液体活检和癌症控制中下一代测序的威力与前景。
Cancer Control. 2020 Jul-Aug;27(3):1073274820934805. doi: 10.1177/1073274820934805.
未来的 CARs。
Am J Hematol. 2019 May;94(S1):S55-S58. doi: 10.1002/ajh.25416. Epub 2019 Feb 25.
4
CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency.CRISPR 介导的启动子或增强子激活可挽救单倍不足引起的肥胖。
Science. 2019 Jan 18;363(6424). doi: 10.1126/science.aau0629. Epub 2018 Dec 13.
5
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.嵌合抗原受体 (CAR) T 疗法治疗血液系统恶性肿瘤:临床观点与意义。
J Immunother Cancer. 2018 Dec 4;6(1):137. doi: 10.1186/s40425-018-0460-5.
6
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout.基于逆转录病毒的瞬时CRISPR/Cas9一体化颗粒用于高效靶向基因敲除
Mol Ther Nucleic Acids. 2018 Dec 7;13:256-274. doi: 10.1016/j.omtn.2018.09.006. Epub 2018 Sep 13.
7
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.用于无痕递送CRISPR-Cas9的水泡性口炎病毒糖蛋白包膜囊泡
Mol Ther Nucleic Acids. 2018 Sep 7;12:453-462. doi: 10.1016/j.omtn.2018.05.010. Epub 2018 Jul 11.
8
Immunity to CRISPR Cas9 and Cas12a therapeutics.对 CRISPR Cas9 和 Cas12a 疗法的免疫。
Wiley Interdiscip Rev Syst Biol Med. 2018 Jan;10(1). doi: 10.1002/wsbm.1408. Epub 2017 Oct 30.
9
The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.用于中枢神经系统疾病基因编辑的自失活 KamiCas9 系统。
Cell Rep. 2017 Sep 19;20(12):2980-2991. doi: 10.1016/j.celrep.2017.08.075.
10
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.通过产后给予 AAV 载体的 CRISPR/Cas9 介导的基因组编辑治愈血友病 B 小鼠。
Sci Rep. 2017 Jun 23;7(1):4159. doi: 10.1038/s41598-017-04625-5.